Abbott Company Profile

What is the competitive landscape for ABBOTT

ABBOTT has one hundred and eleven approved drugs.

Summary for Abbott

US Patents:	0
Tradenames:	89
Ingredients:	62
NDAs:	111
Patent Litigation for Abbott:	See patent lawsuits for Abbott

Drugs and US Patents for Abbott

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	TABLET;ORAL	084539-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Abbott	GENTAMICIN SULFATE	gentamicin sulfate	INJECTABLE;INJECTION	062413-010	Aug 11, 1983		DISCN	No	No
Abbott	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	084413-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Abbott	AMIKACIN SULFATE	amikacin sulfate	INJECTABLE;INJECTION	063266-001	Oct 31, 1994		DISCN	No	No
Abbott	SODIUM BICARBONATE IN PLASTIC CONTAINER	sodium bicarbonate	SOLUTION;INTRAVENOUS	019443-002	Jun 3, 1986		DISCN	Yes	No

Expired US Patents for Abbott

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-002	Dec 14, 1994	5,412,095
Abbott	LOPURIN	allopurinol	TABLET;ORAL	018297-001	Approved Prior to Jan 1, 1982	3,624,205
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-004	Aug 7, 1987	5,294,615
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-002	Aug 7, 1987	5,294,615
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-002	Aug 7, 1987	5,212,176

Paragraph IV (Patent) Challenges for ABBOTT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	100 mg		2010-12-21
	Capsules	10 mg and 15 mg		2009-08-14
	Capsules	100 mg		2012-10-31

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Abbott
• Abbott Labs